Search

The aim of this study is to demonstrate the prevalence of self-reported mask-associated dry eye (MADE) in health-care professionals and the possible risk factors that give rise to MADE. A self-administered questionnaire consisting of 12 questions about MADE and possible risk factors that give rise to MADE was created on web-based "google forms" application, and was then sent to 437 healthcare professionals working in a coronavirus-19 (COVID-19) pandemic hospital, using common telecommunication devices. Three hundred and thirty-three of the 437 health-care professionals, who answered the questionnaire, were included in the study. The prevalence of self-reported MADE among these health-care professionals was found to be 70% (n = 233). Having at least one of the symptoms of dry eye while not having a mask on and advanced age were determined as the possible risk factors for MADE (p =.02 and p <.001, respectively). The clinical examinations of the 195 participants, who had self-reported MADE and accepted the invitation to undergo a clinical evaluation with respect to the symptoms of MADE, revealed that only 60 (30.7%) of these participants had aqueous-type dryness with staining on the ocular surface with fluorescein. The high prevalence of self-reported MADE among health-care professionals can be attributed to the prolonged use of masks associated with longer working hours. Therefore, it is important that the ocular complaints of professionals are addressed by ophthalmology consultants/ophthalmologists during these difficult times. [ABSTRACT FROM AUTHOR]

Copyright of Current Retina Journal / Güncel Retina Dergisi is the property of Anadolu Kitabevi Basim Yayim Medikal Turizm Kirtasiye Tic. Ltd. Sti. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of MN Opthalmology / MN Oftalmoloji is the property of Medical Network and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The aim of this study was to examine the effects of long-term use of hydroxychloroquine (HQ) on the pachymetric, aberrometric, and densitometric values of the cornea and corneal endothelium in lupus patients. Twenty-two eyes (study group) of 22 patients using HQ for treatment of lupus and 25 eyes (control group) of 25 healthy individuals were included in this prospective study. A specular microscopy was used to measure corneal endothelial cell density (ECD), percentage of hexagonal cells (HEX%), coefficient of variation of the cell size (CV). Then, a Pentacam® HR corneal tomography system was used to measure central corneal thickness (CCT), corneal aberrometry values in 6-mm pupil diameters and corneal densitometry values in 6-mm corneal zones (0–2 mm and 2–6 mm). While ECD was significantly lower in the study group than in the control group (p = 0.034), CCT was significantly higher in the study group (p = 0.032). The higher-order aberrations values and the anterior corneal densitometry values in the 0–2 mm and 2–6 mm corneal zones in the study group were found to be significantly higher than the control group (p = 0.021, p = 0.007 and p = 0.013). Prolonged use of HQ may cause some changes in the cornea. In the follow-up of these cases, detailed examination of the cornea as well as the macula may be important for the protection of corneal health. [ABSTRACT FROM AUTHOR]

Purpose: The aim of this study was to investigate the ocular findings observed in patients with coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 and to present the relationship between ocular involvement, systemic findings, and laboratory results. Material and Methods: This cross‐sectional study was carried out between 1 May and 30 June 2020. The study included 359 patients diagnosed with COVID‐19 and assessed by clinical evaluation, nasopharyngeal polymerase chain reaction, and lung computed tomography. Results: One hundred ninety‐seven (54.9%) of the patients were male and 162 (45.1%) were female. The mean age of the patients was 58.5 years (20‐91). Two hundred ninety‐four (81.9%) patients were treated in the inpatient clinic and 65 (18.1%) patients were treated in the intensive care unit. Various ocular diseases were observed in 16 (4.5%) of the patients. Although the rate of ocular disease was 12 out of 294 (4.1%) in patients followed up in the inpatient clinic, this rate was 4 out of 65 (6.2%) in intensive care patients. There was no systemic problem in one patient, in whom conjunctival hyperemia was the first and only reason for admission to the hospital. Four patients followed up in the inpatient clinic had conjunctivitis at the time of admission, and conjunctivitis occurred in three patients during hospitalization. Subconjunctival hemorrhage occurred in five patients and vitreous hemorrhage in one patient. Conclusion: Ocular diseases are uncommon in COVID‐19 patients but may occur during the first period of the disease or during follow‐up. Ocular diseases may be the initial or only sign of COVID‐19 infection. Highlights: Ocular diseases are not common in patients with COVID‐19. Ocular diseases may occur during the initial period of infection or during follow‐up. The most frequently reported ocular finding in patients with COVID‐19 to date is conjunctivitis. Conjunctivitis may be the initial and only sign of COVID‐19 in some patients. Ocular symptoms of COVID‐19 are often self‐limiting and can be treated with symptomatic treatment. [ABSTRACT FROM AUTHOR]

Purpose: To evaluate the effects of topical 0.1% cyclosporin treatment on topographic, pachymetric, and densitometric maps of the cornea in severe pediatric cases of vernal keratoconjunctivitis (VKC). Materials and Methods: Thirty eyes of 30 pediatric patients with severe VKC were included in this study. The symptom and sign scores of these VKC patients were calculated and examinations were performed before and 6 months after topical 0.1% cyclosporin treatment. Pre and post-treatment values of flat keratometry (K1), steep K (K2), maximum K (Kmax), central corneal thickness (CCT), corneal volume (CV), anterior, center, posterior and total densitometry values (in two corneal concentric zones: 0-2-mm and 2-6-mm) were compared. Results: The mean CCT and CV values decreased from 546.85±28.20 to 539.85±25.21 µm and 60.9±3.2 to 60.1±3.0 mm3, respectively (p<0.001, both of them). Keratometry values (K1, K2, and Kmax) did not change after treatment (p:0.787, p:0.464 and p:0.963, respectively). The anterior, center, and total densitometry values in the 0-2-mm and 2-6-mm concentric corneal zones were significantly decreased after treatment (p<0.001, for all values). Conclusions: In severe pediatric VKC patients, topical cyclosporine therapy provides reduction in densitometric (increased corneal transparency), CCT and CV values and also improves symptoms and findings. [ABSTRACT FROM AUTHOR]

Copyright of Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Most ON cases are associated with multiple sclerosis (MS), which is seen in 20% of patients. A diagnosis is usually made from the patient's history and fundoscopic examination, and confirmed by magnetic resonance imaging (MRI); it tends to improve with steroid therapy ("The Clinical Profile of Optic Neuritis" [9]). Third-generation progestins are more advanced than first-generation progestins, but in the long-term use of COCs, progestins may antagonise oestrogen activity, leading to ocular complications. [Extracted from the article]